New for 2019:

  • In-House and Judicial Perspectives on SPC: Examining SPC application controversies in light of the manufacturing waiver and Article 3(a)
  • European Patent Office Keynote on Antibodies
  • Focus on the U.S.: Updates on Recent Written Description and SS101 Patentability Requirements in U.S.
  • Commercial considerations for patent data plausibility through digital apps
  • Practical perspectives on gene editing patenting
  • Focus on Digital Health: Algorisms and digital apps to enhance patent portfolios

 

Agenda at a Glance

 
PRE-CONFERENCE WORKSHOPS  |  October 14, 2019
 
9:00 – 1:00
Workshop A: International Secondary Medical Use Patenting Strategy Working Group: Creating Value and Sustaining Cost Efficiencies on Your Next Patent Application
13:00 – 16:00
WORKSHOP B: International Biosimilars Think Tank: Exploring the Biosimilar Landscape in the U.S. and Europe
 
MAIN CONFERENCE DAY 1  |  October 15, 2019
 
9:00
Opening Remarks from the Chair
9:10
Implementing the SPC Manufacturing Waiver Amendment: Innovator vs. Generic
10:30
Networking Refreshment Break
11:00
Secondary Medical Use Under Cross Examination: A Study of SMU Infringement Scope through the Pregabalin (UK) and Östrogenblocker (Germany) Decisions
12:00
Networking Lunch
1:00
U.S. Antibody Update: The Impact of New U.S. Written Description Guidelines on Monoclonal Antibodies
2:00
U.S. Patent Eligibility: Examining Revised Section 101 Guidance
3:00
Networking Break
3:30
Product Lifecycle Management: Analysing the Interplay of IP Protection Tools Available Beyond Patents and SPCs
4:30
Conclusion of Day 1
 
MAIN CONFERENCE DAY 2 | OCTOBER 16, 2019
 
9:00
Co-Chairs’ Opening Speech
9:10
Analysing Recent Interpretations of Article 3(a) – Going Beyond Simple Infringement
10:10
Networking Break
10:30
In-House Counsel SPC Application Q&A:Practical Advice on How to Succeed in the SPC Application Process in Light of Recent Developments
11:30
Biologics Business Strategy Cage Match: Wise Investments for Biologics and Biosimilars in the U.S.
12:30
Networking Lunch
1:30
Examining Algorisms and Digital Apps Related to Patent Protection
2:30
Networking Break
3:00
Exploring Controversies Surrounding the Patentability of Gene-Editing Processes
3:45
A Switch on a Switch on a Switch: The Status of Harmonization Biotech Patent Law in Europe
4:30
Conference Concludes